KEQU - Kewaunee Scientific Corporation

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
4/30/2022
4/30/2021
4/30/2020
Total Revenue
215,223
168,872
147,469
147,540
Cost of Revenue
180,669
144,652
123,476
124,113
Gross Profit
34,554
24,220
23,993
23,427
Operating Expense
29,650
26,828
26,462
25,772
Operating Income
4,904
-2,608
-2,469
-2,345
Net Non Operating Interest Income Expense
-1,426
-632
-389
-493
Other Income Expense
1,043
755
241
-28
Pretax Income
4,521
-2,485
-2,617
-2,866
Tax Provision
4,584
3,518
990
1,758
Net Income Common Stockholders
-629
-6,126
-3,672
-4,687
Diluted NI Available to Com Stockholders
-629
-6,126
-3,672
-4,687
Basic EPS
-
-2.20
-1.33
-1.70
Diluted EPS
-
-2.20
-1.33
-1.70
Basic Average Shares
-
2,786
2,760
2,750
Diluted Average Shares
-
2,786
2,760
2,750
Total Operating Income as Reported
4,904
-2,608
-1,316
-2,345
Total Expenses
210,319
171,480
149,938
149,885
Net Income from Continuing & Discontinued Operation
-629
-6,126
-3,672
-4,687
Normalized Income
-629
-6,126
-3,672
-4,687
Interest Expense
1,426
632
389
493
Net Interest Income
-1,426
-632
-389
-493
EBIT
5,947
-1,853
-2,228
-2,373
EBITDA
8,766
-
-
-
Reconciled Cost of Revenue
180,669
144,652
123,476
124,113
Reconciled Depreciation
2,819
2,769
2,687
2,654
Net Income from Continuing Operation Net Minority Interest
-629
-6,126
-3,672
-4,687
Normalized EBITDA
8,766
-1,853
-2,228
-2,373
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0

Yahoo Finance Plus Essential access required.

Learn more